[go: up one dir, main page]

PL3463281T3 - Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania - Google Patents

Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania

Info

Publication number
PL3463281T3
PL3463281T3 PL17733738.3T PL17733738T PL3463281T3 PL 3463281 T3 PL3463281 T3 PL 3463281T3 PL 17733738 T PL17733738 T PL 17733738T PL 3463281 T3 PL3463281 T3 PL 3463281T3
Authority
PL
Poland
Prior art keywords
beta
dosage forms
inhibitory activity
aerosol dosage
elastase inhibitory
Prior art date
Application number
PL17733738.3T
Other languages
English (en)
Inventor
Piet BRUIJNZEEL
Johann Zimmermann
Philip BARTH
Eric Chevalier
Christian Ludin
Manfred Keller
Original Assignee
Spexis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spexis Ag filed Critical Spexis Ag
Publication of PL3463281T3 publication Critical patent/PL3463281T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
PL17733738.3T 2016-05-31 2017-05-31 Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania PL3463281T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16020210 2016-05-31
PCT/EP2017/025157 WO2017207118A1 (en) 2016-05-31 2017-05-31 Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof

Publications (1)

Publication Number Publication Date
PL3463281T3 true PL3463281T3 (pl) 2022-11-07

Family

ID=56108445

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17733737.5T PL3463280T3 (pl) 2016-05-31 2017-05-31 Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania
PL17733738.3T PL3463281T3 (pl) 2016-05-31 2017-05-31 Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17733737.5T PL3463280T3 (pl) 2016-05-31 2017-05-31 Peptydomimetyk beta zakręt o działaniu hamującym elastazę i jego aerozolowe formy dawkowania

Country Status (27)

Country Link
US (3) US11235023B2 (pl)
EP (2) EP3463280B1 (pl)
JP (4) JP7286319B6 (pl)
KR (2) KR102480800B1 (pl)
CN (3) CN109195580A (pl)
AU (2) AU2017273507B2 (pl)
BR (2) BR112018074532B1 (pl)
CA (2) CA3024521C (pl)
CL (2) CL2018003391A1 (pl)
DK (2) DK3463280T3 (pl)
EA (2) EA201892819A1 (pl)
ES (2) ES2928050T3 (pl)
HR (2) HRP20221185T1 (pl)
HU (2) HUE060119T2 (pl)
IL (2) IL263112B2 (pl)
LT (2) LT3463281T (pl)
MA (2) MA45168A (pl)
MX (2) MX2018014425A (pl)
PH (2) PH12018502521A1 (pl)
PL (2) PL3463280T3 (pl)
PT (2) PT3463281T (pl)
RS (2) RS63622B1 (pl)
SG (3) SG11201810138XA (pl)
SM (2) SMT202200404T1 (pl)
UA (2) UA125900C2 (pl)
WO (2) WO2017207117A1 (pl)
ZA (2) ZA201807772B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2928050T3 (es) * 2016-05-31 2022-11-15 Spexis Ag Peptidomimético de horquilla beta con actividad inhibidora de elastasa y formas de dosificación en aerosol del mismo
CN114761015A (zh) * 2019-08-23 2022-07-15 Ph制药有限公司 中性粒细胞弹性蛋白酶抑制剂在肺病中的用途
AU2021213776A1 (en) * 2020-01-30 2022-08-25 Vertex Pharmaceuticals Incorporated Methods of treatment for alpha-1 antitrypsin deficiency
EP4247338A2 (en) * 2020-11-23 2023-09-27 Spexis AG Compositions of a beta-hairpin peptidomimetic and aerosol dosage forms thereof
CN116421704A (zh) * 2023-02-20 2023-07-14 成都佩德生物医药有限公司 多肽pd-dp-005在制备治疗肺部疾病药物中的应用及其药物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938331B1 (en) 1996-11-01 2002-12-18 XOMA Technology Ltd. Therapeutic uses of bpi protein products in cystic fibrosis patients
US20060188555A1 (en) * 2005-01-21 2006-08-24 Micheal Cormier Therapeutic peptide formulations with improved stability
CA2915175C (en) 2005-02-17 2019-04-09 Polyphor Ltd. Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
EP1981572B1 (en) * 2006-02-09 2012-11-21 Kamada Ltd. Pulmonary delivery of alpha-i proteinase inhibitor
TR201807714T4 (tr) * 2006-02-10 2018-06-21 Pari Pharma Gmbh İnhalasyon tedavisine yönelik nebülize antibiyotikler.
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
EP1927373B1 (en) * 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
PL2567691T3 (pl) * 2011-09-12 2015-05-29 Meiji Seika Pharma Co Ltd Kompozycje wodne obejmujące arbekacynę
WO2015096672A1 (zh) 2013-12-23 2015-07-02 石家庄铁道大学 测试装置
WO2015098872A1 (ja) 2013-12-26 2015-07-02 株式会社カネカ 太陽電池のｉ‐ｖ測定方法、太陽電池のｉ‐ｖ測定装置、太陽電池の製造方法、太陽電池モジュールの製造方法、および太陽電池モジュール
HRP20221046T1 (hr) 2013-12-27 2023-01-20 Spexis Ag Beta-ukosni peptidomimetici kao selektivni inhibitori elastaze
CN105873939B (zh) * 2013-12-27 2021-08-27 波利弗尔股份公司 作为选择性弹性蛋白酶抑制剂的β-发夹肽模拟物
ES2928050T3 (es) * 2016-05-31 2022-11-15 Spexis Ag Peptidomimético de horquilla beta con actividad inhibidora de elastasa y formas de dosificación en aerosol del mismo

Also Published As

Publication number Publication date
DK3463280T3 (da) 2022-09-26
IL263112B2 (en) 2023-10-01
EP3463281A1 (en) 2019-04-10
JP7286319B6 (ja) 2023-06-16
SG11201810137UA (en) 2018-12-28
KR20190011750A (ko) 2019-02-07
WO2017207118A1 (en) 2017-12-07
MX393629B (es) 2025-03-24
PT3463280T (pt) 2022-10-07
CN109195580A (zh) 2019-01-11
IL263114B1 (en) 2023-08-01
JP2022078013A (ja) 2022-05-24
US20200230203A1 (en) 2020-07-23
ZA201807773B (en) 2022-07-27
AU2017273508B2 (en) 2022-07-28
HRP20221185T1 (hr) 2022-12-09
CA3024522C (en) 2024-06-25
CL2018003391A1 (es) 2019-05-03
EP3463280B1 (en) 2022-07-06
AU2017273507B2 (en) 2022-03-17
ES2928050T3 (es) 2022-11-15
LT3463281T (lt) 2022-09-26
EA201892818A1 (ru) 2019-05-31
US11235024B2 (en) 2022-02-01
US20220023379A1 (en) 2022-01-27
EP3463280A1 (en) 2019-04-10
HRP20221194T1 (hr) 2022-12-09
EA201892819A1 (ru) 2019-05-31
CA3024521C (en) 2023-06-20
JP7286319B2 (ja) 2023-06-05
HUE060393T2 (hu) 2023-02-28
IL263114A (en) 2018-12-31
PH12018502521A1 (en) 2019-10-21
AU2017273507A1 (en) 2018-12-13
AU2017273508A1 (en) 2018-12-13
CA3024521A1 (en) 2017-12-07
KR102480800B1 (ko) 2022-12-22
SG11201810138XA (en) 2018-12-28
UA125900C2 (uk) 2022-07-06
JP2019523222A (ja) 2019-08-22
US20200230202A1 (en) 2020-07-23
WO2017207117A1 (en) 2017-12-07
CN116159024A (zh) 2023-05-26
EP3463281B1 (en) 2022-07-06
CL2018003390A1 (es) 2019-05-03
RS63639B1 (sr) 2022-10-31
MA45167A (fr) 2019-04-10
US11235023B2 (en) 2022-02-01
ZA201807772B (en) 2022-10-26
EA039603B1 (ru) 2022-02-16
JP2019523763A (ja) 2019-08-29
PL3463280T3 (pl) 2022-11-07
PH12018502522A1 (en) 2019-10-21
CN109310613A (zh) 2019-02-05
UA125899C2 (uk) 2022-07-06
DK3463281T3 (da) 2022-09-26
SG10202113280XA (en) 2021-12-30
SMT202200404T1 (it) 2022-11-18
KR20190015309A (ko) 2019-02-13
RS63622B1 (sr) 2022-10-31
MA45168A (fr) 2019-04-10
BR112018074551B1 (pt) 2022-02-08
LT3463280T (lt) 2022-09-26
HUE060119T2 (hu) 2023-02-28
IL263114B2 (en) 2023-12-01
MX2018014425A (es) 2019-03-28
IL263112B1 (en) 2023-06-01
IL263112A (en) 2018-12-31
US11844823B2 (en) 2023-12-19
BR112018074551A2 (pt) 2019-03-06
KR102511284B1 (ko) 2023-03-16
PT3463281T (pt) 2022-10-07
BR112018074532A2 (pt) 2019-03-19
SMT202200405T1 (it) 2022-11-18
JP2023017793A (ja) 2023-02-07
MX2018014752A (es) 2019-04-25
ES2927948T3 (es) 2022-11-14
BR112018074532B1 (pt) 2022-02-08
CA3024522A1 (en) 2017-12-07
JP7544466B2 (ja) 2024-09-03

Similar Documents

Publication Publication Date Title
IL257706A (en) Peptidomimetic macrocycles and their uses
ZA201807772B (en) Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof
IL254444A0 (en) Peptidomimetic macrocycles and their uses
EP3114217A4 (en) Caspase polypeptides having modified activity and uses thereof
GB201516555D0 (en) Event detection and summarisation
ZA201702162B (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
EP3255059A4 (en) Antimicrobial peptide wy-21 and use thereof
EP3250122A4 (en) Finger ring electrocardiogram monitor trigger systems and associated methods
EP3130345A4 (en) Peptide having fibrosis inhibitory activity and composition containing same
ZA201509326B (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
ZA201702168B (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
EP3274922A4 (en) Reliable fingertip and palm detection
ZA201804864B (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
EP3263584A4 (en) Peptide for targeting autophagic cells and use thereof
IL263682A (en) Antibiotic variants and their uses
IL283619A (en) Compounds with pde9a prophylactic activity, and their medicinal use
EP3305895A4 (en) Beta-galactosidase variant having high transglycosylation activity, and use thereof
HK40093168A (zh) 具有弹性蛋白酶抑制活性的β-发夹肽模拟物及其气雾剂剂量形式
EP3380050C0 (en) FINGERRESTS AND GLOVES WITH IT
IL273655B1 (en) A compound with erk kinase inhibitory activity and its use
GB2568553B (en) Activity detection
IL283620A (en) Compounds with pde9a prophylactic activity, and their medicinal uses
HK40008494A (en) Lantibiotic variants and uses thereof
GB201617726D0 (en) Medicament and assay
AU2015902816A0 (en) Spray device and dosage cartridge